DP
ONCE

DSAM Partners’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

DSAM Partners’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-54,484
Closed -$4.22M – 71
2015
Q1 		$4.22M Buy
+54,484
New +$3.14M 1.03% 34

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

DSAM Partners's ONCE Position: Q2 2015 in Review

DSAM Partners sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q2 2015, closing a stake of 54,484 shares — an estimated $4.22M sold.

DSAM Partners first reported a position in ONCE in Q1 2015 and held it in 1 quarter. The position peaked at $4.22M in Q1 2015. 109 funds tracked by Wall St. Rank hold ONCE as of Q2 2015.

  • DSAM Partners reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
  • DSAM Partners sold 54,484 Spark Therapeutics, Inc. Common Stock shares in Q2 2015, an estimated $4.22M.
  • DSAM Partners first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 1 quarter.
  • DSAM Partners's Spark Therapeutics, Inc. Common Stock position peaked at $4.22M in Q1 2015.
  • 109 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q2 2015.

Based on DSAM Partners's 13F filing for Q2 2015, filed 13 Aug 2015.